Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Debt / NOTE 2.500% 2/1
-
Market price (% of par)
-
104.17%
-
Total 13F principal
-
$21,237,000
-
Principal change
-
-$16,937,000
-
Total reported market value
-
$22,502,961
-
Number of holders
-
11
-
Value change
-
-$17,754,380
-
Number of buys
-
1
-
Number of sells
-
6
Institutional Holders of AMAG PHARMACEUTICALS INC - NOTE 2.500% 2/1 as of Q3 2017
As of 30 Sep 2017 AMAG PHARMACEUTICALS INC - NOTE 2.500% 2/1 had 11 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $21,237,000 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included Birch Grove Capital LP, Bruce & Co., Inc., FMR LLC, SONORA INVESTMENT MANAGEMENT, LLC, JPMORGAN CHASE & CO, Allianz Asset Management GmbH, GOLDMAN SACHS GROUP INC, ROYAL BANK OF CANADA, BANK OF AMERICA CORP /DE/, and North Star Investment Management Corp..
This table shows 11 bond principal holders of the security as of 30 Sep 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par) |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.